IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that Richard Rubino, Chief Financial Officer, will present in a fireside chat discussion at the RBC Capital Markets 2016 Healthcare Conference on Tuesday, February 23, 2016 at 10:30 a.m. Eastern Time in New York, NY. Mr. Rubino will provide an Aerie overview and business update.
